NCI Supercomputer Upgrading Supported By DCBD Board; Could Cost $40 Million Plus Renovations
In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan
DCT Board Questions Funding, Direction Of IL-2/LAK Trials
NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials
Recompetitions Of DCT Contracts Okayed
IM Recommends Pay Increase for Many At NIH, Other Steps; Adamson Objects To “Primrose Path Of Centralization
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









